Sickle Cell Anemia in Children: Clinical Trials

5 trials for Sickle Cell Anemia in Children, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 recruiting, 1 terminated. 5 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Active not recruiting 1, Completed 1, Recruiting 1, Terminated 1, Unknown 1
Phase 32Completed 1, Unknown 1
Phase 11Recruiting 1

Follow Sickle Cell Anemia in Children: new trials by email Literature Review of Sickle Cell Anemia in Children trials Research Report on Sickle Cell Anemia in Children

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study
hydroxycarbamide - Sickle Cell Disease, Sickle Cell Anemia in Children
Phase 1 / Phase 2RecruitingChildren's Hospital Medical Center, Cincinnati2502026-05-132026-07-16
The Effect of Voxelotor on Cerebral Hemodynamic Response in Children With Sickle Cell Anemia
Voxelotor - Sickle Cell Anemia in Children
Phase 2TerminatedEmory University222022-03-282025-12-12
Gum Arabic as Anti-oxidant, Anti-inflammatory and Fetal Hemoglobin Inducing Agent in Sickle Cell Anemia Patients
Acacia Senegal extract, Pectin - Sickle Cell Anemia in Children
Phase 2 / Phase 3UnknownAl-Neelain University1002020-02-152020-01-28
Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia
Omega 3, Vit D, Zinc sulfate - Vaso-occlusive Crisis, Sickle Cell Disease
Phase 2 / Phase 3CompletedBeni-Suef University3502019-11-012021-01-27
Stroke Prevention With Hydroxyurea Enabled Through Research and Education (SPHERE)
Hydroxyurea, Elevated Arm TCD Examination, Normal Arm TCD Examination - Sickle Cell Anemia in Children
Phase 2Active not recruitingChildren's Hospital Medical Center, Cincinnati2022019-04-242026-10-19

Narrower conditions

Anemia, Sickle Cell (3)  ·  Stroke (1)  ·  Vaso-Occlusive Crises (1)  ·  beta-Thalassemia (1)

Broader conditions

Anemia (3)  ·  Anemia, Hemolytic (3)  ·  Anemia, Hemolytic, Congenital (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Hemoglobinopathies (3)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Nervous System Diseases (1)  ·  Thalassemia (1)  ·  Vascular Diseases (1)

Interventions

Hydroxyurea (3)  ·  Cardiovascular Agents (1)  ·  Docosahexaenoic Acids (1)  ·  Gum Arabic (1)  ·  Hydroxymethylglutaryl-CoA Reductase Inhibitors (1)  ·  Morphine (1)  ·  Pectins (1)  ·  Simvastatin (1)  ·  Zinc Sulfate (1)  ·  voxelotor (1)

Sponsors

Children's Hospital Medical Center, Cincinnati (2)  ·  Al-Neelain University (1)  ·  Beni-Suef University (1)  ·  Emory University (1)

Countries

United States (2)  ·  Egypt (1)  ·  Saudi Arabia (1)  ·  Sudan (1)  ·  Tanzania (1)  ·  Uganda (1)

Top investigators

Ahmed F Mahmoud Hussein, MS.c (1)  ·  Amy Tang, MD (1)  ·  Imad M Fdl-Elmula, PhD (1)  ·  Russell E. Ware, MD, PhD (1)

Results publications

PMID 36870358, PMID 38364110